ABM: innovative therapeutic solutions in RNA technology with opportunity in Poland ?
Medical Research Agency (MRA) has informed that the innovative therapeutic solutions, selected in a recent competition, among others, will be…
Medical Research Agency (MRA) has informed that the innovative therapeutic solutions, selected in a recent competition, among others, will be…
Clinical trials on the efficacy of a novel COVID-19 drug Paxlovid will enlist 90 participants. Pfizer, a pharmaceutical corporation based in the…
Scientists from the Australian National University, in collaboration with the Florey Institute of Neuroscience and Mental Health, have developed a…
Israel’s Covid drug EXO-CD24, subjected to Phase II trials in Athens, allowed 29 out of 30 moderate to severe patients to…
Adamed will receive approximately $122m from Acadia Pharmaceuticals Inc. for the sale of a licence to conduct further development work…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.